Screener
Mesa Laboratories MLAB Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Line item | June 30, 2026 | March 31, 2026 |
|---|---|---|
| Unearned revenue | 14,523 | 14,723 |
| Other accrued expenses | 16,536 | 17,616 |
| Term loan, current portion | 5,625 | 5,625 |
| Total current liabilities | 57,322 | 61,898 |
| Noncurrent liabilities: | ||
| Deferred tax liability | 20,046 | 20,085 |
| Non-current operating lease liabilities | 15,852 | 13,662 |
| Term loan, noncurrent portion, net of debt issuance costs | 59,994 | 61,357 |
Document
FAQ
- What is Mesa Laboratories's total current liabilities?
- Mesa Laboratories (MLAB) reported total current liabilities of $57.32M in Q2 2026.
- How has Mesa Laboratories's total current liabilities changed year-over-year?
- Mesa Laboratories's total current liabilities decreased by 61.7% year-over-year, from $149.49M to $57.32M.
- What is the long-term trend for Mesa Laboratories's total current liabilities?
- Over 3 years (2021 to 2026), Mesa Laboratories's total current liabilities has grown at a 23.8% compound annual growth rate (CAGR), from $32.58M to $61.9M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Mesa Laboratories's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude